Johnson & Johnson has announced a new initiative in the United Arab Emirates aimed at supporting access to liquid biopsy testing for patients diagnosed with metastatic non-small cell lung cancer (NSCLC). Through the program, the company will cover the cost of liquid biopsy testing for eligible patients where diagnostic testing may not be covered by […] The post Johnson & Johnson Launches Initiative to Support Access to Liquid Biopsy Testing for Non-Small Cell Lung Cancer in the UAE appeared first on Web-Release.